Genomic analyses of recombinant adenovirus type 11a in China.
Whole-genome sequencing of human adenovirus type 11 (HAdV-11) strain QS, isolated in China, was conducted, and its sequence was compared with the sequences of strains within the species of HAdVs. The HAdV-11 QS genome contains 34,755 nucleotides. Similar to the other HAdV subgenus B sequences, the HAdV-11 QS genome coded 37 functional proteins and could be divided into four early, two intermediate, and five late transcription regions. The amino acid sequences of the fiber and the hypervariable regions (HVRs) within the hexon gene of HAdV-11 QS were identical to the corresponding sequences of the HAdV-11a strain; further analyses that compared those amino acid sequences with the amino acid sequences of the HAdV species subgenus B:2 strains revealed that the highest degree of homology (>99.2%) existed between HAdV-11 QS and the prototypical HAdV-14 strain, except for a few coding sequences of HVRs within the hexon gene, DNA polymerase, pVI, and pre-terminal protein. This indicate that HAdV-11 strain QS, isolated in China, is a recombinant adenovirus of HAdV-14, and the recombination analyses also confirmed this finding. It is difficult to clarify the time and manner of the recombination, and further investigations are required to determine whether the emergence of recombination between HAdV-11a and HAdV-14 might increase virulence, thereby posing a new global challenge with regard to acute respiratory diseases in the near future.
Yang
Zhaohui
Z
State Key Laboratory for Molecular Virology & Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 27, Nanwei Road, Xuanwu District, Beijing 100050, People's Republic of China.
Zhu
Zhen
Z
Tang
Liuying
L
Wang
Li
L
Tan
Xiaojuan
X
Yu
Pengbo
P
Zhang
Yong
Y
Tian
Xiaoping
X
Wang
Jingjun
J
Zhang
Yan
Y
Li
Dexin
D
Xu
Wenbo
W
D000258:Adenovirus Infections, Human / Q000821:virology*; D000260:Adenoviruses, Human / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D002681:China; D016000:Cluster Analysis; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics*; D019143:Evolution, Molecular; D020869:Gene Expression Profiling; D016679:Genome, Viral; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D011995:Recombination, Genetic; D017422:Sequence Analysis, DNA; D017386:Sequence Homology, Amino Acid; D014764:Viral Proteins / Q000235:genetics
D004279:DNA, Viral; D014764:Viral Proteins
J Virol. 2005 Feb;79(4):2559-72
15681456
Mol Cell. 2005 Jan 7;17(1):121-35
15629723
J Med Virol. 2005 Oct;77(2):232-7
16121380
Mol Ther. 2000 Jan;1(1):18-30
10933908
Hum Gene Ther. 2004 Dec;15(12):1167-76
15684694
J Virol. 2002 Nov;76(21):10608-16
12368303
J Virol. 2002 Oct;76(19):10056-9
12208985
J Clin Microbiol. 2009 Mar;47(3):697-703
19109466
J Gen Virol. 2004 Sep;85(Pt 9):2615-2625
15302955
J Gen Virol. 2008 Feb;89(Pt 2):380-388
18198368
Clin Infect Dis. 2008 Feb 1;46(3):421-5
18173356
J Virol. 2003 Sep;77(17):9183-91
12915534
Cell. 1993 Apr 23;73(2):309-19
8477447
Virology. 2003 Apr 25;309(1):152-65
12726735
J Virol. 1976 Aug;19(2):643-58
957484
Intervirology. 1991;32(6):338-50
1657824
J Biol Chem. 1991 Aug 15;266(23):15075-9
1869542
J Virol. 2001 Nov;75(21):10446-54
11581412
J Virol. 1998 Oct;72(10):7860-70
9733823
J Virol. 2007 Jun;81(11):5978-84
17360747
J Virol. 1996 Mar;70(3):1396-405
8627656
J Virol. 2001 Aug;75(15):7131-41
11435594
J Trop Pediatr. 2004 Oct;50(5):279-84
15510759
Virology. 1995 Feb 20;207(1):32-45
7871747
J Virol. 1990 Jun;64(6):2732-42
2335816
EMBO J. 1992 Feb;11(2):761-8
1537347
Epidemiol Infect. 1988 Dec;101(3):503-9
2850936
J Gen Virol. 2000 Nov;81(Pt 11):2573-2604
11038369
J Virol. 1989 Sep;63(9):3612-21
2760976
J Mol Biol. 1989 Jul 5;208(1):195-8
2769752
Biochemistry. 2002 Jan 15;41(2):652-9
11781106
EMBO J. 1983;2(8):1357-65
10872331
J Infect Dis. 2007 Nov 15;196(10):1465-73
18008225
J Med Virol. 1996 Feb;48(2):151-6
8835348